These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17420728)

  • 1. Pharma consolidates its grip on post-antibody landscape.
    Sheridan C
    Nat Biotechnol; 2007 Apr; 25(4):365-6. PubMed ID: 17420728
    [No Abstract]   [Full Text] [Related]  

  • 2. The decreased number of new drug approvals (NDAs) has been a topic of considerable debate over the past decade. Preface.
    Enna SJ; Williams M
    Adv Pharmacol; 2009; 57():xi-ii. PubMed ID: 19945649
    [No Abstract]   [Full Text] [Related]  

  • 3. Market watch: upcoming market catalysts in Q2 2011.
    Jeng R
    Nat Rev Drug Discov; 2011 Apr; 10(4):248. PubMed ID: 21455226
    [No Abstract]   [Full Text] [Related]  

  • 4. Market watch: upcoming market catalysts in Q1 of 2010.
    Rosenthal J
    Nat Rev Drug Discov; 2010 Jan; 9(1):11. PubMed ID: 20043022
    [No Abstract]   [Full Text] [Related]  

  • 5. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Market watch: upcoming market catalysts in Q1 2013.
    Inui E
    Nat Rev Drug Discov; 2013 Jan; 12(1):12. PubMed ID: 23274459
    [No Abstract]   [Full Text] [Related]  

  • 7. Market watch: Upcoming market catalysts in Q3 2013.
    Roybal D
    Nat Rev Drug Discov; 2013 Jul; 12(7):496. PubMed ID: 23812261
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibiotics: a shot in the arm.
    Leeb M
    Nature; 2004 Oct; 431(7011):892-3. PubMed ID: 15496888
    [No Abstract]   [Full Text] [Related]  

  • 9. Market watch: Upcoming market catalysts in Q4 2013.
    Fong S
    Nat Rev Drug Discov; 2013 Oct; 12(10):731. PubMed ID: 24080689
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunology: Pimp my antibody.
    Check E
    Nature; 2007 Apr; 446(7139):964-6. PubMed ID: 17460636
    [No Abstract]   [Full Text] [Related]  

  • 11. Roche consolidates grip on anti-angiogenesis market.
    Moran N
    Nat Biotechnol; 2008 Oct; 26(10):1055-6. PubMed ID: 18846054
    [No Abstract]   [Full Text] [Related]  

  • 12. A testing approach based on tiny doses still awaits big results.
    Coombs A
    Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
    [No Abstract]   [Full Text] [Related]  

  • 13. Market watch: Upcoming market catalysts in Q2 2013.
    Nguyen K
    Nat Rev Drug Discov; 2013 Apr; 12(4):254. PubMed ID: 23535926
    [No Abstract]   [Full Text] [Related]  

  • 14. Big Pharma's Commedia.
    Steele FR
    Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
    [No Abstract]   [Full Text] [Related]  

  • 15. Market watch: key clinical and regulatory events in Q2 2010.
    Hay M
    Nat Rev Drug Discov; 2010 Apr; 9(4):261. PubMed ID: 20357797
    [No Abstract]   [Full Text] [Related]  

  • 16. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 19. The special treatment.
    Osborne R
    Nat Biotechnol; 2008 May; 26(5):487-9. PubMed ID: 18464770
    [No Abstract]   [Full Text] [Related]  

  • 20. Indian pharma enters the global arena.
    Singh S
    Cell; 2007 Mar; 128(5):811-4. PubMed ID: 17350563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.